Literature DB >> 25434946

Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.

Nicola Boari1, Michele Bailo, Filippo Gagliardi, Alberto Franzin, Marco Gemma, Antonella del Vecchio, Angelo Bolognesi, Piero Picozzi, Pietro Mortini.   

Abstract

OBJECT: Since the 1990 s, Gamma Knife radiosurgery (GKRS) has become the first-line treatment option for small- to medium-size vestibular schwannomas (VSs), especially in patients without mass effect-related symptoms and with functional hearing. The aim of this study was to assess the safety and efficacy of GKRS, in terms of tumor control, hearing preservation, and complications, in a series of 379 consecutive patients treated for VS.
METHODS: Of 523 patients treated at the authors' institution for VS between 2001 and 2010, the authors included 379 who underwent GKRS as the primary treatment. These patients were not affected by Type 2 neurofibromatosis and had clinical follow-up of at least 36 months. Clinical follow-up (mean and median 75.7 and 69.5 months, respectively) was performed for all patients, whereas audiometric and quantitative radiological follow-up examinations were obtained for only 153 and 219 patients, respectively. The patients' ages ranged from 23 to 85 years (mean 59 years). The mean tumor volume was 1.94 ± 2.2 cm(3) (median 1.2 cm(3), range 0.013-14.3 cm(3)), and the median margin dose was 13 Gy (range 11-15 Gy). Parameters considered as determinants of the clinical outcome were long-term tumor control, hearing preservation, and complications. A statistical analysis was performed to correlate clinical outcomes with the radiological features of the tumor, dose-planning parameters, and patient characteristics.
RESULTS: Control of the tumor with GKRS was achieved in 97.1% of the patients. In 82.7% of the patients, the tumor volume had decreased at the last follow-up, with a mean relative reduction of 34.1%. The rate of complications was very low, with most consisting of a transient worsening of preexisting symptoms. Patients who had vertigo, balance disorders, or facial or trigeminal impairment usually experienced a complete or at least significant symptom relief after treatment. However, no significant improvement was observed in patients previously reporting tinnitus. The overall rate of preservation of functional hearing at the long-term follow-up was 49%; in patients with hearing classified as Gardner-Robertson (GR) Class I, this value was 71% and reached 93% among cases of GR Class I hearing in patients younger than 55 years.
CONCLUSIONS: Gamma Knife radiosurgery is a safe and effective treatment for VS, achieving tumor control in 97.1% of cases and resulting in a very low morbidity rate. Younger GR Class I patients had a significantly higher probability of retaining functional hearing even at the 10-year follow-up; for this reason, the time between symptom onset, diagnosis, and treatment should be shortened to achieve better outcomes in functional hearing preservation.

Entities:  

Keywords:  CN = cranial nerve; GKRS = Gamma Knife radiosurgery; GR = Gardner-Robertson; Gamma Knife; HB = House-Brackmann; IAC = internal acoustic canal; IAM = internal acoustic meatus; NF2 = Type 2 neurofibromatosis; PTA = pure tone average; VS = vestibular schwannoma; acoustic neuroma; hearing preservation; mobile phone; oncology; radiosurgery; stereotactic radiosurgery; vestibular schwannoma

Mesh:

Year:  2014        PMID: 25434946     DOI: 10.3171/2014.8.GKS141506

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  34 in total

1.  Stereotactic radiotherapy of vestibular schwannoma : Hearing preservation, vestibular function, and local control following primary and salvage radiotherapy.

Authors:  Florian Putz; Jan Müller; Caterina Wimmer; Nicole Goerig; Stefan Knippen; Heinrich Iro; Philipp Grundtner; Ilker Eyüpoglu; Karl Rössler; Sabine Semrau; Rainer Fietkau; Sebastian Lettmaier
Journal:  Strahlenther Onkol       Date:  2016-12-07       Impact factor: 3.621

2.  The natural history of vestibular schwannoma growth-prospective 40-year data from an unselected national cohort.

Authors:  Martin Reznitsky; Mette Marie Babiel Schmidt Petersen; Niels West; Sven-Eric Stangerup; Per Cayé-Thomasen
Journal:  Neuro Oncol       Date:  2021-05-05       Impact factor: 12.300

3.  Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation.

Authors:  Zhiping Chen; Keiichi Takehana; Takashi Mizowaki; Megumi Uto; Kengo Ogura; Katsuyuki Sakanaka; Yoshiki Arakawa; Yohei Mineharu; Yuki Miyabe; Nobutaka Mukumoto; Susumu Miyamoto; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2018-03-19       Impact factor: 3.402

Review 4.  The emerging role of hearing loss rehabilitation in patients with vestibular schwannoma treated with Gamma Knife radiosurgery: literature review.

Authors:  Carlotta Morselli; N Boari; M Artico; M Bailo; L O Piccioni; I Giallini; M de Vincentiis; P Mortini; P Mancini
Journal:  Neurosurg Rev       Date:  2020-02-06       Impact factor: 3.042

5.  Evaluation of Auditory Pathways Using DTI in Patients Treated with Gamma Knife Radiosurgery for Acoustic Neuroma: A Preliminary Report.

Authors:  Serpil Kurtcan; Mustafa Aziz Hatiboglu; Alpay Alkan; Huseyin Toprak; Mehmet Hakan Seyithanoglu; Ayse Aralasmak; Bahar Atasoy; Omer Uysal
Journal:  Clin Neuroradiol       Date:  2017-03-03       Impact factor: 3.649

6.  Radiotherapy for vestibular schwannoma: Review of recent literature results.

Authors:  Giuseppina Apicella; Marina Paolini; Letizia Deantonio; Laura Masini; Marco Krengli
Journal:  Rep Pract Oncol Radiother       Date:  2016-02-28

7.  Impact of Cochlear Dose on Hearing Preservation following Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma.

Authors:  Lawrance K Chung; Nolan Ung; John P Sheppard; Thien Nguyen; Carlito Lagman; Winward Choy; Stephen Tenn; Nader Pouratian; Percy Lee; Tania Kaprealian; Michael Selch; Antonio De Salles; Quinton Gopen; Isaac Yang
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-10

8.  Twelve-year results of LINAC-based radiosurgery for vestibular schwannomas.

Authors:  Paola Anselmo; Michelina Casale; Fabio Arcidiacono; Fabio Trippa; Rossella Rispoli; Lorena Draghini; Sara Terenzi; Alessandro Di Marzo; Ernesto Maranzano
Journal:  Strahlenther Onkol       Date:  2019-08-05       Impact factor: 3.621

9.  Long-Term Hearing Outcomes Following Stereotactic Radiosurgery in Vestibular Schwannoma Patients-A Retrospective Cohort Study.

Authors:  Peter L Santa Maria; Yangyang Shi; Richard K Gurgel; C Eduardo Corrales; Scott G Soltys; Chloe Santa Maria; Kevin Murray; Steven D Chang; Nikolas H Blevins; Iris C Gibbs; Robert K Jackler
Journal:  Neurosurgery       Date:  2019-10-01       Impact factor: 4.654

10.  Systematic Review of Hearing Preservation After Radiotherapy for Vestibular Schwannoma.

Authors:  Adam R Coughlin; Tyler J Willman; Samuel P Gubbels
Journal:  Otol Neurotol       Date:  2018-03       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.